Viewing Study NCT02991651


Ignite Creation Date: 2025-12-24 @ 11:44 PM
Ignite Modification Date: 2026-02-18 @ 4:26 AM
Study NCT ID: NCT02991651
Status: TERMINATED
Last Update Posted: 2025-05-14
First Post: 2016-12-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of IRX4204 With Erlotinib in Previously Treated Advanced NSCLC
Sponsor: Io Therapeutics
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: IRX4204 NSCLC 1 01 2015
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View